Foghorn Therapeutics Statistics
NASDAQ: FHTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.09+0.12 (+6.09%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.04 -2.39%
Foghorn Therapeutics by the numbers
Foghorn Therapeutics has a market capitalization of $124.1 million based on 59.39M shares outstanding. With trailing EPS of $-0.98, Foghorn Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 58.1% below its 50-day average and 58.4% below its 200-day average.
Average daily trading volume is 617.56K shares, or about $1.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FHTX valuation vs. peer median
| Metric | FHTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $124.12M | $114.84M | +8% |
| Avg. volume | 617.56K | 677.62K | -9% |
Peer median across 8 companies: COYA, INO, UNCY, RANI, GNLX, QUCY, PMVP, VTVT.
Valuation
- Market cap
- $124.12M
- EPS (TTM)
- $-0.98
- Shares outstanding
- 59.39M
Price and trading
- Previous close
- 1.97
- Open
- 1.92
- Day range
- 1.91 – 2.15
- 52-week range
- 1.79 – 7.61
- 52-week change
- -52.71%
- Beta
- —
- Volume
- 913.13K
- Average volume
- 617.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 124.12M
- Forward Pe
- -2.04
- Eps
- -0.98
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.61
- Week52 Low
- 1.79
- Avg Volume
- 617.56K
- Shares Outstanding
- 59.39M
- Ma50
- 4.99
- Ma200
- 5.02
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -72.54%
- Pct From52w Low
- 16.76%